The New York Times Is at It Again Regarding Patents | McDonnell Boehnen Hulbert & Berghoff LLP
It's always good to have a villain, a "Snidely Whiplash" or other cartoon caricature to support an argument, especially if the issue is complex and fails the cocktail party test...
New York United States Amgen Neupogen Amjevita Amgen Sandoz Filgrastim Biosimilar Professor Adam Mossoff At George Mason University
Source: jdsupra.com